GC never publicly said he merged DX with Avant because of their clean balance sheet. Of course Gregg Linn made that point in presentations that Avant has a clean balance sheet to attract investor interest. AMBS's shares in Avant aren't confined to paying off the toxics- they are collateralized, but it is up to AMBS how they pay the toxics off. Avant can pay for the uplist from the proceeds of a funding raised by them. They might have had to pay a retainer, so a small part of the million dollar notes AMBS signed with Dominick may be allocated towards that.
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links